Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleArticle

ADRENERGIC BLOCKING AND CARDIOVASCULAR EFFECTS OF A NEW N-SUBSTITUTED TETRAHYDROISOQTJINOLINE (NC 7197)

PHILIP J. PRIVITERA, THERON BLICKENSTAFF, THOMAS E. GAFFNEY and SHAKIL MOHAMMED
Journal of Pharmacology and Experimental Therapeutics March 1971, 176 (3) 655-661;
PHILIP J. PRIVITERA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
THERON BLICKENSTAFF
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
THOMAS E. GAFFNEY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SHAKIL MOHAMMED
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

A new N-substituted tetrahydroisoquinoline derivative, NC 7197, was investigated for its effects on alpha adrenergic receptors and on the cardiovascular system. The i.v. injection of 0.3 to 10 mg/kg of this compound in anesthetized dogs produced a fall in arterial pressure and increases in cardiac rate and contractile force. After pretreatment with hexamethonium, reserpine or phenoxybenzamine, a presser response to NC 7197 was observed. The positive chronotropic and inotropic effects of NC 7197 were absent in the dog heart-lung preparation; these cardiac effects were also reduced or abolished after beta adrenergic blockade, ganglionic blockade and catecholamine depletion. Acutely denervated, perfused hindlegs of dogs were used to evaluate the effects of the drug on alpha adrenergic receptors. NC 7197, 0.3 to 30 mg/kg, significantly reduced hindleg pressor responses to i.a. norepinephrine, 0.1 to 10 µg. With increasing doses, NC 7197 produced a progressive shift to the right in the dose-response curve for norepinephrine. The duration of blockade was 6 to 10 hours. These results indicate that NC 7197 is a competitive alpha adrenergic blocking agent. Its hypotensive effect appears to be related to the alpha adrenergic blocking activity of the drug on vascular smooth muscle. The data also suggest that the positive chronotropic effect of the drug is the result of a reflex increase in sympathetic tone in response to the decrease in arterial pressure.

Footnotes

    • Received September 3, 1970.
    • Accepted November 16, 1970.
  • © 1971 by The Williams & Wilkins Co.

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 176, Issue 3
1 Mar 1971
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
ADRENERGIC BLOCKING AND CARDIOVASCULAR EFFECTS OF A NEW N-SUBSTITUTED TETRAHYDROISOQTJINOLINE (NC 7197)
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

ADRENERGIC BLOCKING AND CARDIOVASCULAR EFFECTS OF A NEW N-SUBSTITUTED TETRAHYDROISOQTJINOLINE (NC 7197)

PHILIP J. PRIVITERA, THERON BLICKENSTAFF, THOMAS E. GAFFNEY and SHAKIL MOHAMMED
Journal of Pharmacology and Experimental Therapeutics March 1, 1971, 176 (3) 655-661;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

ADRENERGIC BLOCKING AND CARDIOVASCULAR EFFECTS OF A NEW N-SUBSTITUTED TETRAHYDROISOQTJINOLINE (NC 7197)

PHILIP J. PRIVITERA, THERON BLICKENSTAFF, THOMAS E. GAFFNEY and SHAKIL MOHAMMED
Journal of Pharmacology and Experimental Therapeutics March 1, 1971, 176 (3) 655-661;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • PST3093 Stimulates SERCA2a and Improves Cardiac Function
  • CRV431 Decreases Liver Fibrosis and Tumor Development
  • Reduction of 5-Hydroxytryptamine (5-HT)1A-Mediated Temperature and Neuroendocrine Responses and 5-HT1A Binding Sites in 5-HT Transporter Knockout Mice
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics